Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from GlaxoSmithKline Pharmaceuticals Limited ( (IN:GLAXO) ).
GlaxoSmithKline Pharmaceuticals Limited has responded to queries from stock exchanges regarding a recent sharp increase in trading volumes of its shares, stating that it has fully complied with all disclosure requirements under SEBI’s listing regulations and has not withheld any material or price-sensitive information that could affect its operations or performance. The company emphasized that the spike in trading activity is purely market driven and reiterated its commitment to continue informing the exchanges of any future price-sensitive developments, aiming to reassure investors and regulators about the transparency of its disclosures and governance practices.
More about GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals Limited is an Indian pharmaceutical company engaged in the research, manufacturing and marketing of prescription medicines and vaccines, with a strong presence in key therapeutic areas in the domestic healthcare market.
Average Trading Volume: 4,209
Technical Sentiment Signal: Hold
Current Market Cap: 419.6B INR
For detailed information about GLAXO stock, go to TipRanks’ Stock Analysis page.